Sung-Hwan Cho
Directeur Général chez CHOA PHARMACEUTICAL CO., LTD.
Fortune : 2 M $ au 30/04/2024
Postes actifs de Sung-Hwan Cho
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Directeur/Membre du Conseil | 18/02/2002 | - |
| Directeur Général | - | - | |
| President | - | - | |
Medipharm
 Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Directeur Général | - | - |
| President | - | - |
Historique de carrière de Sung-Hwan Cho
Formation de Sung-Hwan Cho
| Korea University | Undergraduate Degree |
| Chung-Ang University | Graduate Degree |
Statistiques
Internationale
| Corée du Sud | 5 |
Opérationnelle
| President | 2 |
| Chief Executive Officer | 2 |
| Director/Board Member | 1 |
Sectorielle
| Consumer Services | 3 |
| Health Technology | 2 |
| Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
- Bourse
- Insiders
- Sung-Hwan Cho
- Expérience